Evidence map›Paper›PMID 34572402›Full record

ArticleBiomedicines2021

Complementary Effect of Non-Persistent Silver Nano-Architectures and Chlorhexidine on Infected Wound Healing.

Mykola Pernakov, Maria Laura Ermini, Oksana Sulaieva, Domenico Cassano, Marco Santucci, Yevhenia Husak, Viktoriia Korniienko, Giulia Giannone, Aziza Yusupova, Iryna Liubchak and 5 more

Abstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mykola PernakovSumy State University, 40007 Sumy, Ukraine.ORCID 0000-0002-7048-7446
Maria Laura ErminiCenter for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, 56127 Pisa, Italy.
Oksana SulaievaMedical Laboratory CSD, 03148 Kyiv, Ukraine.
Domenico CassanoCenter for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, 56127 Pisa, Italy.ORCID 0000-0002-3394-3393
Marco SantucciCenter for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, 56127 Pisa, Italy.
Yevhenia HusakSumy State University, 40007 Sumy, Ukraine.
Viktoriia KorniienkoSumy State University, 40007 Sumy, Ukraine.
Giulia GiannoneCenter for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, 56127 Pisa, Italy.ORCID 0000-0002-4630-7177
Aziza YusupovaSumy State University, 40007 Sumy, Ukraine.
Iryna LiubchakSumy State University, 40007 Sumy, Ukraine.
Maria Teodora HristovaMedical University of Pleven, 5800 Pleven, Bulgaria.
Anton SavchenkoSumy State University, 40007 Sumy, Ukraine.
Viktoriia HolubnychaSumy State University, 40007 Sumy, Ukraine.
Valerio VolianiCenter for Nanotechnology Innovation @NEST, Istituto Italiano di Tecnologia, 56127 Pisa, Italy.ORCID 0000-0003-1311-3349
Maksym PogorielovSumy State University, 40007 Sumy, Ukraine.ORCID 0000-0001-9372-7791

Funding

European Commission 777926Ministry of Education and Science of Ukraine 0120U101972Ukrainian National Research Fund 2020.02/0223
6 · The paper itself

Abstract

Surgical site infection (SSI) substantially contributes each year to patients' morbidity and mortality, accounting for about 15% of all nosocomial infections. SSI drastically increases the rehab stint and expenses while jeopardizing health outcomes. Besides prevention, the treatment regime relies on an adequate antibiotic therapy. On the other hand, resistant bacterial strains have currently reached up to 34.3% of the total infections, and this percentage grows annually, reducing the efficacy of the common treatment schemes. Thus, new antibacterial strategies are urgently demanded. Here, we demonstrated in rats the effectiveness of non-persistent silver nano-architectures (AgNAs) in infected wound healing together with their synergistic action in combination with chlorhexidine. Besides the in vivo efficacy evaluation, we performed analysis of the bacteriological profile of purulent wound, histological evaluations, and macrophages polarization quantifications to further validate our findings and elucidate the possible mechanisms of AgNAs action on wound healing. These findings open the way for the composition of robust multifunctional nanoplatforms for the translation of safe and efficient topical treatments of SSI.

Indexed as

antimicrobialsnanomaterialssilversurgical site infectionswound healing

Identifiers

PMID34572402
PMCPMC8469683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.